This page collects WhisperX intelligence signals tagged #Medical Technology. It is designed for humans, search engines, and AI agents: each item links to a canonical source-backed record with sector, source, timestamp, credibility, and exportable structured data.
Cytosorbents Corporation has been formally notified by Nasdaq that it is not in compliance with a continued listing rule, triggering a potential delisting from the exchange. The company disclosed the notice in an 8-K filing with the SEC, a mandatory step that signals immediate regulatory and market pressure. This devel...
Hologic CEO Steve MacMillan will step down upon the completion of the company's planned go-private transaction, marking a definitive leadership transition tied directly to a major corporate restructuring. This move signals a deliberate shift in governance as the medical technology firm prepares to exit the public marke...
Neuronetics, the commercial-stage medical technology company, is facing a sudden leadership vacuum in its financial operations. Chief Financial Officer Steven Pfanstiel is departing the company, triggering an immediate search for his successor. This unexpected exit of a key C-suite executive introduces immediate uncert...
A new smart contact lens has demonstrated the dual capability to continuously monitor intraocular pressure and deliver glaucoma medication on-demand in early-stage testing. This development directly targets the silent, insidious nature of glaucoma—the world's second-leading cause of blindness—where an estimated half of...
Stryker Corporation has formally disclosed a material cybersecurity incident in a filing with the U.S. Securities and Exchange Commission. The disclosure, made via an amended 8-K form, triggers mandatory reporting requirements under Item 1.05, which is reserved for significant cybersecurity events that a company determ...
A proposed class-action lawsuit has thrust two major California healthcare providers into a legal and ethical firestorm over the alleged secret use of an AI transcription tool. Several patients have sued Sutter Health and MemorialCare, alleging the Abridge AI system was used to record their confidential medical convers...
NEXGEL is projecting a significant leap in its financial scale, anticipating pro forma annual revenue of approximately $35 million following its strategic acquisition of the wound care segment from Celularity Inc. This move instantly reshapes the hydrogel technology company's market position, transforming its revenue p...
Beta Bionics has issued a significant financial projection, forecasting 2026 revenue in the range of $131 million to $136 million. In a parallel move signaling confidence in its operational efficiency, the company has also raised its long-term gross margin outlook to a robust 57.5% to 59.5%. This dual announcement mark...